Abstract:Viruses are a group of widespread organisms that are often responsible for very dangerous diseases, as most of them follow a mechanism to multiply and infect their hosts as quickly as possible. Pathogen viruses also mutate regularly, with the result that measures to prevent virus transmission and recover from the disease caused are often limited. The development of new substances is very time-consuming and highly budgeted and requires the sacrifice of many living organisms. Computational chemistry methods allow faster analysis at a much lower cost and, most importantly, reduce the number of living organisms sacrificed experimentally to a minimum. Ionic liquids (ILs) are a group of chemical compounds that could potentially find a wide range of applications due to their potential virucidal activity. In our study, we conducted a complex computational analysis to predict the antiviral activity of ionic liquids against three surrogate viruses: two nonenveloped viruses, Listeria monocytogenes phage P100 and Escherichia coli phage MS2, and one enveloped virus, Pseudomonas syringae phage Phi6. Based on experimental data of toxic activity (logEC90), we assigned activity classes to 154 ILs. Prediction models were created and validated according to the Organization for Economic Co-operation and Development (OECD) recommendations using the Classification Tree method. Further, we performed an external validation of our models through virtual screening on a set of 1277 theoretically generated ionic liquids and then selected 10 active ionic liquids, which were synthesized to verify their activity against the analyzed viruses. Our study proved the effectiveness and efficiency of computational methods to predict the antiviral activity of ionic liquids. Thus, computational models are a cost-effective alternative approach compared with time-consuming experimental studies where live animals are involved.

The development of polyoxometalates as antivirus drugs

Synthesis and anti-influenza virus activity of polyoxometalates containing amantadine

Vanadium-substituted Keggin structured polyoxometalate combined with fluconazole in α-SiW11V-FKZ for efficient bacterial inhibition

Hybrid Machine Learning and Experimental Studies of Antiviral Potential of Ionic Liquids against P100, MS2, and Phi6

Application of Antiviral Polyoxometalates to Living Environments—Antiviral Moist Hand Towels and Stationery Items

Polyoxometalates and their composites for antimicrobial applications: Advances, mechanisms and future prospects

Polyoxometalate exerts broad-spectrum activity against human respiratory viruses hampering viral entry.

Sodium Polyoxotungstate Inhibits the Replication of Influenza Virus by Blocking the Nuclear Import of vRNP

Potent Antiviral and Antimicrobial Polymers as Safe and Effective Disinfectants for the Prevention of Infections

Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy

Discovery and development of antiviral drugs

Progress in the Synthesis of Heteropolyoxometalate Clusters Andtheir Applications in Biological Treatment

Recent Developments in Antimicrobial and Antiviral Agents Based on Natural/Synthetic Polymers and Dendrimers: Design and Therapeutic Applications

Sequence Analysis of Reassortants Within H3N2 Subtype Influenza A Virus Circulated in Hong Kong, 2014–2017

Recent advances in antiviral activities and potential mechanisms of sulfated polysaccharides

Spontaneous and continuous anti-virus disinfection from nonstoichiometric perovskite-type lanthanum manganese oxide

Polymeric antibacterial materials: design, platforms and applications

Natural products as potential lead compounds to develop new antiviral drugs over the past decade

Clinical Applications of Antiviral Agents

Virology research and development of antiviral drugs

Recent progress in the antiviral activity and mechanism study of pentacyclic triterpenoids and their derivatives